Dong Zhang
![dong1 dong1](https://www.elabnyc.com/wp-content/uploads/2020/03/dong1.png)
ALT therapeutics
Affiliations
New York Institute of Technology
Technologies
Therapeutic
Indication
Oncology
Executive Summary
View/DownloadWebsite
www.linkedin.comWe discovered that inhibition of FANCM prevents the survival of ALT cancers (10-15% of cancers) and planned to develop FANCM inhibitors to treat ALT cancers.